A novel strategy for NQO1 (NAD(P)H:quinone oxidoreductase, EC 1.6.99.2) mediated therapy of bladder cancer based on the pharmacological properties of EO9.
Publication date
2001Author
Choudry, Guzanfar A.Hamilton Stewart, P.A.
Double, John A.
Krul, M.R.L.
Naylor, Brian
Flannigan, G. Michael
Shah, Tariq K.
Phillips, Roger M.
Peer-Reviewed
Yes